KSS
36
2
DGX
28
4
SLB
41
2
ECL
54
5
THC
52
9
PEG
53
7
MSFT
55
2
EMR
57
7
VRSK
54
2
CMS
57
2
PRU
39
3
CAH
44
7
NOV
45
2
UPS
51
6
MHK
25
5
AAP
26
5
ABBV
40
5
NKE
36
2
AMP
43
2
LUV
45
3
KSS
36
2
DGX
28
4
SLB
41
2
ECL
54
5
THC
52
9
PEG
53
7
MSFT
55
2
EMR
57
7
VRSK
54
2
CMS
57
2
PRU
39
3
CAH
44
7
NOV
45
2
UPS
51
6
MHK
25
5
AAP
26
5
ABBV
40
5
NKE
36
2
AMP
43
2
LUV
45
3
Financhill
Back

Apellis Pharmaceuticals Vs. Biomarin Pharmaceutical Industry Stock Comparison

Buy
53

APLS
Apellis Pharmaceuticals

Last Price:
$33.18
Seasonality Move:
14.66%
Buy
60

BMRN
Biomarin Pharmaceutical

Last Price:
$65.65
Seasonality Move:
5.39%
Buy
53
Apellis Pharmaceuticals (APLS) is a Buy

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $33.18. The Score for APLS is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $65.69. The Score for BMRN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $33.18
    The current trend is moderately bullish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $65.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.92 Buy
Relative Strength Index (14 RSI): 53.6 Buy
Chaikin Money Flow: -2104619 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.64 - 35.1) Buy
Bollinger Bands (100): (28.23 - 37.21) Buy

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.22 Sell
Relative Strength Index (14 RSI): 48.8 Sell
Chaikin Money Flow: 1709604 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.56 - 66.54) Buy
Bollinger Bands (100): (64.13 - 84.07) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.56 Sell
20-day SMA: 33.63 Sell
50-day SMA: 30.14 Buy
200-day SMA: 39.25 Sell
8-day EMA: 33.57 Sell
20-day EMA: 32.94 Buy
50-day EMA: 31.96 Buy
200-day EMA: 38.48 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 65.79 Sell
20-day SMA: 65.64 Buy
50-day SMA: 66.69 Sell
200-day SMA: 78.92 Sell
8-day EMA: 65.67 Buy
20-day EMA: 65.74 Sell
50-day EMA: 67.62 Sell
200-day EMA: 77.02 Sell

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.77 per share, and an increase next year of $0.82 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.90 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):